Unraveling neuronal and metabolic alterations in neurofibromatosis type 1
Authors:
Open Access
- 31 August 2024
- journal article
- review article
- Published by Springer Nature in Journal of Neurodevelopmental Disorders
- Vol. 16 (1) , 1-16
Abstract
Neurofibromatosis type 1 (OMIM 162200) affects ~ 1 in 3,000 individuals worldwide and is one of the most common monogenetic neurogenetic disorders that impacts brain function. The disorder affects various organ systems, including the central nervous system, resulting in a spectrum of clinical manifestations. Significant progress has been made in understanding the disorder’s pathophysiology, yet gaps persist in understanding how the complex signaling and systemic interactions affect the disorder. Two features of the disorder are alterations in neuronal function and metabolism, and emerging evidence suggests a potential relationship between them. This review summarizes neurofibromatosis type 1 features and recent research findings on disease mechanisms, with an emphasis on neuronal and metabolic features.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01 NS097237, R01 NS126361, R01 NS114403, R01 NS124716, R21 NS124198, F31 NS124245)
This publication has 213 references indexed in Scilit:
- Early history of the different forms of neurofibromatosis from ancient Egypt to the British Empire and beyond: First descriptions, medical curiosities, misconceptions, landmarks, and the persons behind the syndromesAmerican Journal of Medical Genetics Part A, 2018
- Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1JAMA Psychiatry, 2016
- Multiple increased osteoclast functions in individuals with neurofibromatosis type 1American Journal of Medical Genetics Part A, 2011
- Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register serviceAmerican Journal of Medical Genetics Part A, 2010
- Brain Morphometry, T2-Weighted Hyperintensities, and IQ in Children With Neurofibromatosis Type 1Archives of Neurology, 2005
- Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytesGlia, 2001
- Developmental regulation of a neuron-specific neurofibromatosis 1 isoformAnnals of Neurology, 1999
- Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1American Journal of Medical Genetics, 1999
- Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissuesDevelopmental Dynamics, 1995
- NeurofibromatosisArchives of Neurology, 1988